These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 28333373

  • 21. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA.
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [Abstract] [Full Text] [Related]

  • 22. Avoiding implantation of a cardioverter-defibrillator by bridging with wearable defibrillator vest.
    Klein N, Kuntz T, Dhein S.
    Herz; 2021 Mar; 46(2):172-177. PubMed ID: 31555894
    [Abstract] [Full Text] [Related]

  • 23. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.
    Zishiri ET, Williams S, Cronin EM, Blackstone EH, Ellis SG, Roselli EE, Smedira NG, Gillinov AM, Glad JA, Tchou PJ, Szymkiewicz SJ, Chung MK.
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):117-28. PubMed ID: 23275233
    [Abstract] [Full Text] [Related]

  • 24. J Waves Are Associated With the Increased Occurrence of Life-Threatening Ventricular Tachyarrhythmia in Patients With Nonischemic Cardiomyopathy.
    Naruse Y, Nogami A, Shinoda Y, Hanaki Y, Shirai Y, Kowase S, Kurosaki K, Machino T, Kuroki K, Yamasaki H, Igarashi M, Sekiguchi Y, Aonuma K.
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1448-1453. PubMed ID: 27593399
    [Abstract] [Full Text] [Related]

  • 25. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M, Weyand M, Seitz T, Harig F.
    Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13048. PubMed ID: 36723848
    [Abstract] [Full Text] [Related]

  • 26. Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II Substudy.
    Mueller-Leisse J, Brunn J, Zormpas C, Hohmann S, Hillmann HAK, Eiringhaus J, Bauersachs J, Veltmann C, Duncker D.
    Sensors (Basel); 2022 Mar 05; 22(5):. PubMed ID: 35271182
    [Abstract] [Full Text] [Related]

  • 27. Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator.
    Kim M, Kim J, Lee JH, Hwang YM, Kim MS, Nam GB, Choi KJ, Kim JJ, Kim YH.
    J Cardiovasc Electrophysiol; 2016 Oct 05; 27(10):1191-1198. PubMed ID: 27334231
    [Abstract] [Full Text] [Related]

  • 28. Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy.
    Middour TG, Rosenthal TM, Abi-Samra FM, Bernard ML, Khatib S, Polin GM, Rogers PA, Bober RM, Morin DP.
    J Cardiovasc Electrophysiol; 2020 May 05; 31(5):1137-1146. PubMed ID: 32064730
    [Abstract] [Full Text] [Related]

  • 29. Use of the wearable cardioverter-defibrillator - the Swiss experience.
    Kovacs B, Reek S, Sticherling C, Schaer B, Linka A, Ammann P, Brenner R, Krasniqi N, Müller AS, Dzemali O, Kobza R, Grebmer C, Haegeli L, Berg J, Mayer K, Schläpfer J, Domenichini G, Reichlin T, Roten L, Burri H, Eriksson U, Saguner AM, Steffel J, Duru F, Swiss Wcd Registry.
    Swiss Med Wkly; 2020 Sep 21; 150():w20343. PubMed ID: 33035354
    [Abstract] [Full Text] [Related]

  • 30. A wearable cardioverter defibrillator with a low false alarm rate.
    Poole JE, Gleva MJ, Birgersdotter-Green U, Branch KRH, Doshi RN, Salam T, Crawford TC, Willcox ME, Sridhar AM, Mikdadi G, Beinart SC, Cha YM, Russo AM, Rowbotham RK, Sullivan J, Gustavson LM, Kivilaid K.
    J Cardiovasc Electrophysiol; 2022 May 21; 33(5):831-842. PubMed ID: 35174572
    [Abstract] [Full Text] [Related]

  • 31. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
    Antonini L, Pasceri V, Mollica C, Ficili S, Poti G, Aquilani S, Santini M, La Rocca S.
    J Cardiovasc Med (Hagerstown); 2011 May 21; 12(5):334-9. PubMed ID: 21487343
    [Abstract] [Full Text] [Related]

  • 32. Use of the Wearable Cardioverter-Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry.
    El-Battrawy I, Koepsel K, Tenbrink D, Kovacs B, Dreher TC, Blockhaus C, Gotzmann M, Klein N, Kuntz T, Shin DI, Lapp H, Rosenkaimer S, Abumayyaleh M, Hamdani N, Saguner AM, Kowitz J, Erath JW, Duru F, Mügge A, Akin I, Aweimer A, Beiert T.
    J Am Heart Assoc; 2023 Sep 19; 12(18):e030615. PubMed ID: 37681569
    [Abstract] [Full Text] [Related]

  • 33. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW, Vamos M, Sirat AS, Hohnloser SH.
    Clin Res Cardiol; 2017 Apr 19; 106(4):300-306. PubMed ID: 27888304
    [Abstract] [Full Text] [Related]

  • 34. Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator.
    Takahashi A, Shiga T, Shoda M, Tanizaki K, Manaka T, Ejima K, Kasanuki H, Hagiwara N.
    Heart Vessels; 2010 Mar 19; 25(2):150-4. PubMed ID: 20339977
    [Abstract] [Full Text] [Related]

  • 35. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.
    Pacing Clin Electrophysiol; 2010 Jun 01; 33(6):696-704. PubMed ID: 20059719
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ventricular tachycardia in nonischemic cardiomyopathy: Anteroseptal vs inferolateral origin based on ICD ventricular electrogram timing.
    Kodali S, Shirai Y, Muser D, Callans DJ, Marchlinski FE, Santangeli P.
    J Cardiovasc Electrophysiol; 2019 Nov 01; 30(11):2334-2343. PubMed ID: 31433089
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM, Bense J, Hohenforst-Schmidt W.
    J Interv Card Electrophysiol; 2021 Nov 01; 62(2):401-407. PubMed ID: 33200285
    [Abstract] [Full Text] [Related]

  • 40. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ.
    JACC Clin Electrophysiol; 2017 Mar 01; 3(3):243-250. PubMed ID: 29759518
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.